Slucare Clinical Pathology is categorized under Medical Labs in Saint Louis, MO and active since 2007.
Slucare Clinical Pathology was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Michael Creer at the company’s single location by writing to 3635 Vista Avenue Floor 4, Saint Louis, Missouri MO 63110 or by phoning (314) 268-5275. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Slucare Clinical Pathology |
| Contact Person: | Michael Creer |
| Address: | 3635 Vista Avenue Floor 4, Saint Louis, Missouri 63110 |
| Phone Number: | (314) 268-5275 |
| Website Address: | path.slu.edu |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Slucare Clinical Pathology was started in 2007 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Michael Creer for inquiries that concern Slucare Clinical Pathology by calling the company number (314) 268-5275, as your correspondence is most welcome. Additionally, the physical location of the single location of Slucare Clinical Pathology can be found at the coordinates 38.622698,-90.239464 as well as the street address 3635 Vista Avenue Floor 4 in Saint Louis, Missouri 63110.
For its online presence, you may visit Slucare Clinical Pathology’s website at path.slu.edu and engage with its social media outlets through on Twitter and on Facebook.